athyrium capital management  athyrium opportunities fund aof investor login aof i portal aof ii portal athyrium opportunities fund aof aof ii aof i previous investments athyrium opportunities fund company marketer  counterparty product initial investment date medpro safety products greiner bioone vacuette safety system february 0 biofire diagnostics biofire filmarray september 0 verenium verenium various december 0 ironwood pharmaceuticals ironwood and forest laboratories linzess january 0 syncardia systems inc syncardia total artificial heart march 0 progenity inc progenity inc various genetic tests june 0 tria beauty inc tria beauty skincare products july 0 innopharma inc various marketing partners specialty injectable and ophthalmic generic pharmaceuticals october 0 horizon pharma inc horizon pharma various nsaids and actimmune november 0 universal biosensors inc lifescan jj and siemens point of care poc diagnostics december 0 pernix therapeutics holdings inc pernix treximet and others february 04 ikaria inc ikaria inomax february 04 vivus inc vivus inc qsymia and stendraspedra february 04 synarcbiocore holdings llc synarcbiocore holdings specialty clinical research services march 04 retrophin inc alamo pharma services inc chenodal  thiola july 04 tecomet inc tecomet orthopedic and other contract manufacturing services december 04 zealand pharma as sanofi lyxumia december 04 lannett company inc lannett company inc generic pharmaceuticals december 05  this table lists all investments made by the athyrium opportunities fund home  medpro safety products  mpsp medpro about us board of directorsnews and announcementscontact us investor relations safety products drug deliveryphlebotomyambienativanklonopinmeridiasomatramadolvaliumxanax 45 rose news  annoucements all news  annoucements previous next medpro agrees to sell patents on three blood collection and infusion products to greiner bioone agreement will also eliminate  million of medpro longterm debt » read more medpro makes charitable donation to sandy hook in lieu of sending holiday cards happy holidays from medpro » read more find medpro at cphi in madrid meet us at innopack  icse booth 0j this event is located at the feria madr » read more medpro safety products and weimer pharma announce marketing partnership lexington ky  rastatt germany – august  0 – medpro safety products inc » read more medpro signs letter of intent with specialty pharmaceutical company lexington ky – july 6 0 – medpro safety products inc otcbbmpsp a lea » read more crystal research provides update on medpro safety products recent update on medpro safety products published by crystal research reports » read more medpro safety products to participate in two key industry conferences company to highlight its innovative drug delivery solutions at 0 aaps nationa » read more medpro featured in drug development  delivery may issue prefilled syringes  a container of choice for pharma features medpros prefil » read more whitepaper featured on occupational health  safety website a call to safety why current safety devices are not solving the needlestick is » read more medpro safety products releases 0 financial results reports on progress and recent corporate developments » read more survey reveals market demand for new prefilled drug delivery platform medpro seeks partnerships to commercialize new cartridge platform safety syring » read more ondrugdelivery publication features medpro article download medpros feature article in ondrugdelivery » read more 0 medpro inc all rights reserved terms of use  privacy policy contact  site map syndromic infectious disease diagnostics  biofire diagnostics menu home products solutions for healthcare providers for labs for customers filmarray filmarray® link software panels testimonials request a demo research for payors company mission  values careers contact media conferences  events press releases press kit support video library faq continuing education return forms documents sign up for updates  this iframe contains the logic required to handle ajax powered gravity forms syndromic testing the right test the first time rapidly identify infections with symptomdriven testing for healthcare providersfor labsfor customers filmarray® the fastest way to better results the filmarray system from biofire is the new standard for syndromic infectious disease diagnostics simple fast and comprehensive the filmarray delivers accurate results in about an hour the right test the first time can impact all areas of patient care healthcare providers can see faster diagnoses and improved antibiotic stewardship labs can see improved efficiency and reduced costs and downstream testing read more filmarray ® panels the five fdacleared filmarray panels test for viruses bacteria parasites yeast and antimicrobial resistance genes whether you’re trying to select appropriate therapy for a septic patient or determine exactly which respiratory pathogen is making a young child sick the filmarray® system can return answers fast learn more respiratory blood culture id gastrointestinal meningitis biofire diagnostics leading the way with more than 5 years of molecular experience biofire diagnostics llc sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing as biomérieux’s global center of excellence for molecular diagnostics no other company has fdacleared and ceivd marked assays for more pathogens biofire diagnostics has produced the easiest fastest and most comprehensive multiplex pcr system available the filmarray learn more unique values for clinics labs and customers the combination of fast easy and comprehensive is really powerful these characteristics define the filmarray® system for clinics labs and current customers biofire’s molecular diagnostic solutions provide unique value   for healthcare providers the biofire filmarray® helps healthcare providers improve patient care and satisfaction by providing faster and better results learn more for labs the biofire filmarray easily integrates into clinical laboratories allowing for relevant molecular testing around the clock learn more for customers easy access to information and resources to help current customers use biofire products with confidence learn more request a filmarray demo are you ready to order the filmarray or want to request a free demo please fill out this form to take the next step towards faster results our team is ready to answer all of your questions request a demo enzymes cookies help us deliver our services by using our services you agree to our use of cookies learn more ok close choose a basf website asia pacific americas europe middle east  africa basf global asia pacific americas europe middle east  africa close select your language basf global  this page is available in the following languages english close logged in error logging out hello you are logged in with access to additional information basf ecommerce platform logout login invalid login credentials please login with your username and password username password keep me logged in forgot your password you want to purchase products or view order status from basf se basf ecommerce platform would you like to register to get personalized information register here to get additional information like specific downloads register to basfcom registration is successful lorem ipsum doloramet conseteture sadipscing registration is unsuccessful lorem ipsum doloramet consetetur back to registration form firstname lastname company country please choose your country please choose your country industry please choose your industry sub industry please choose subindustry please choose subindustry street number postal code city phone email desired password repeat password basf user agreement details basf user agreement basf user agreement register you want to purchase products or view order status from basf se basf ecommerce platform forgot your password please provide your registered email id to reset your password reset password link has been sent to provided registration email id please provide a valid registered email id email submit enzymes enzymes contact   basf  we create chemistry  home products  industries  enzymes industrial enzyme solutions basf is a recognized pioneer in the development and commercialization of highperformance enzymes for use in industrial processes basf sells enzymes developed using its unique rd capabilities to satisfy the needs of the global market leveraging its unique patented technology the company harnesses the power of nature and creates products that maximize efficiency while improving environmental performance global challengesthe global population is estimated to reach  billion by 050 major challenges to support that growth include having enough water food and energy for all while meeting expectations of rising living standards at basf we believe through creating chemistry and leveraging industrial biotechnology we will be able to meet these challenges markets we serve why enzymesfrom enzymes in detergents to enzymes which enhance the nutrition of the food we eat enzymes are part of our everyday lives they make the products we use daily more efficient are naturally biodegradable and have a great safety profile enzymes are part of a growing movement towards the biobased economy why enzymes innovate with uswe invite potential collaborators and customers to engage with basf to jointly collaborate and solve problems together work with us our scienceour technology platform harnesses all of nature’s biodiversity and brings that biodiversity to the commercial realm via enzyme products what we do share linkedin facebook twitter google email print ironwood pharmaceuticals skip to main content you are now leaving ironwoodpharmacom you are now leaving ironwoodpharmacom this link will take you to a website to which our privacy policy does not apply you are solely responsible for your interactions with that website the art and science of making medicineswe’re focused on three goals transforming knowledge into medicines that make a difference for patients creating value that will inspire the continued support of our fellow shareholders and building a team that passionately pursues excellence recent news 0ironwood pharmaceuticals to host second quarter  investor update call »0ironwood pharmaceuticals reports positive topline results from iw8 phase iib trial in uncontrolled gastroesophageal reflux disease » in our analytical chemistry lab inside ironwood building a topperforming commercial biotech company we are focusing on several important franchises including ibsccic refractory gerd uncontrolled gout and vascular and fibrotic diseases find out more » click here for full us prescribing information including boxed warning »learn more about linzess® »click here for full us prescribing information including limitations of use and boxed warning »learn more about zurampic® » members of our analytical pharmacology team ironwood pharmaceuticals  binney street cambridge ma 04 tel 66 fax 644 about us overview core values management team founders board of directors pharmaceutical advisory committee contact us transparency our medicines overview discovery of linaclotide global strategy rd overview key programs approach collaborate overview accessing additional products globalization investors overview business principles events corp governance financial information stock information investor faqs press releases investor contacts news overview press releases social media multimedia resources join us overview career openings sales openings our community our expertise copyright   ironwood pharmaceuticals inc all rights reserved        privacy policy        terms of service       site design linzess® is a registered trademark of ironwood pharmaceuticals inc zurampic® duzallo™ are registered trademarks of astrazeneca ab corporation or its affiliates and are used herein under license athyrium capital management  athyrium opportunities fund aof investor login aof i portal aof ii portal athyrium opportunities fund aof aof ii aof i previous investments athyrium opportunities fund company marketer  counterparty product initial investment date medpro safety products greiner bioone vacuette safety system february 0 biofire diagnostics biofire filmarray september 0 verenium verenium various december 0 ironwood pharmaceuticals ironwood and forest laboratories linzess january 0 syncardia systems inc syncardia total artificial heart march 0 progenity inc progenity inc various genetic tests june 0 tria beauty inc tria beauty skincare products july 0 innopharma inc various marketing partners specialty injectable and ophthalmic generic pharmaceuticals october 0 horizon pharma inc horizon pharma various nsaids and actimmune november 0 universal biosensors inc lifescan jj and siemens point of care poc diagnostics december 0 pernix therapeutics holdings inc pernix treximet and others february 04 ikaria inc ikaria inomax february 04 vivus inc vivus inc qsymia and stendraspedra february 04 synarcbiocore holdings llc synarcbiocore holdings specialty clinical research services march 04 retrophin inc alamo pharma services inc chenodal  thiola july 04 tecomet inc tecomet orthopedic and other contract manufacturing services december 04 zealand pharma as sanofi lyxumia december 04 lannett company inc lannett company inc generic pharmaceuticals december 05  this table lists all investments made by the athyrium opportunities fund athyrium capital management  athyrium funds investor login aof i portal aof ii portal athyrium  our funds overview our funds our history aof ii in may 05 athyrium announced a final closing for the athyrium opportunities fund ii aof ii or the fund the fund has 50 of committed capital the fund is focused on making structured investments in the broader healthcare and life sciences sectors including pharmaceuticals biologics biotechnology specialty and generic pharmaceuticals medical devices and products laboratory and diagnostics products and services healthcare services and healthcare information technology the fund is focused on generating current income and capital gains and has significant flexibility in structuring its investments–possible transaction structures include loans or other highyielding credit investments with or without warrant coverage royalties or royaltybacked investments structured securities preferred stock or convertible securities the fund seeks to make attractive riskadjusted returns and looks to partner with management teams and to provide long term capital to assist in building their businesses the fund can also engage in secondary market transactions aof ii is a successor fund to the athyrium opportunities fund aof i which had a final closing in march 0 with 5 million of committed capital separate accounts since its founding athyrium has formed a number of separate account relationships in order to focus on specific opportunities within the life sciences sector nb athyrium llc served as a predecessor to the athyrium opportunities fund athyrium opportunities fund iii nonus a lp  list of ceos founders and company directors directorpedianet  list of ceos founders board members and company directors athyrium opportunities fund iii nonus a lp list of persons related to the company athyrium opportunities fund iii nonus a lp find out list of ceos founders board members and company directors of athyrium opportunities fund iii nonus a lp cik number 6048company address co athyrium capital management lp 5 fifth avenue floor 5 new york 0phone number 65 people related to athyrium opportunities fund iii nonus a lp namepositionstreetcitycountryc hyman andrewco athyrium capital management lp 5 fifth avenue floor 5new yorknypaul courtneyco athyrium capital management lp 5 fifth avenue floor 5new yorknystrong elinco athyrium capital management lp 5 fifth avenue floor 5new yorknya ferrell jeffreyco athyrium capital management lp 5 fifth avenue floor 5new yorknyd lack jeremyco athyrium capital management lp 5 fifth avenue floor 5new yorknya wakefield paulco athyrium capital management lp 5 fifth avenue floor 5new yorkny athyrium opportunities fund iii nonus a lp on the web related companiesathyrium healthcare strategic income  growth idf llc athyrium opportunities fund b lp athyrium opportunities fund ii nonus lp athyrium opportunities fund ii lp athyrium opportunities fund iib master lp athyrium opportunities fund iii nonus b lp athyrium opportunities fund iii lp athyrium partners lp   bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright  0 · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version athyrium opportunities fund iii lp  who is raising money  sec filings of fundraisings and investments in hedge funds startups and private equity companies who is raising money athyrium opportunities fund iii lp funding details athyrium opportunities fund iii lp industry pooled investment fundcik number 6048address co athyrium capital management lp 5 fifth avenue floor 5 new york 0phone number 65 latest news athyrium opportunities fund iii lp raised 55 from  investors on  athyrium opportunities fund iii lp filings datefiling typeofferedsoldremainingmin investmentinvest countexemption  exlusions new form dindefinite55indefinite0b c csec filing athyrium opportunities fund iii lp raised 55 in total directors and executives of athyrium opportunities fund iii lp key people in athyrium opportunities fund iii lp andrew hymanpaul wakefieldcourtney paulelin strongjeffrey ferrelljeremy lack similar companiesathyrium partners lp athyrium opportunities fund b lp athyrium opportunities fund ii nonus lp athyrium opportunities fund ii lp athyrium opportunities fund iib master lp athyrium opportunities fund iii nonus a lp athyrium opportunities fund iii nonus b lp athyrium healthcare strategic income  growth idf llc last visited companies cig plenastrategy fund lp clearleap inc congress lake co cpdfci lp cedar bluff  ltd  whoisraisingmoneycom daily updated news about investment into startups hedge funds and private equity companies athyrium opportunities fund iii nonus a lp  who is raising money  sec filings of fundraisings and investments in hedge funds startups and private equity companies who is raising money athyrium opportunities fund iii nonus a lp funding details athyrium opportunities fund iii nonus a lp industry pooled investment fundcik number 6048address co athyrium capital management lp 5 fifth avenue floor 5 new york 0phone number 65 latest news athyrium opportunities fund iii nonus a lp raised  from  investors on  athyrium opportunities fund iii nonus a lp filings datefiling typeofferedsoldremainingmin investmentinvest countexemption  exlusions new form dindefiniteindefiniteb c csec filing athyrium opportunities fund iii nonus a lp raised  in total directors and executives of athyrium opportunities fund iii nonus a lp key people in athyrium opportunities fund iii nonus a lp andrew hymanpaul wakefieldcourtney paulelin strongjeffrey ferrelljeremy lack similar companiesathyrium partners lp athyrium opportunities fund b lp athyrium opportunities fund ii nonus lp athyrium opportunities fund ii lp athyrium opportunities fund iib master lp athyrium opportunities fund iii nonus b lp athyrium opportunities fund iii lp athyrium healthcare strategic income  growth idf llc last visited companies aqr style premia alphaport fund lp aqr style premia offshore fund ii lp ares european real estate cayman feeder fund iv lp all party system co american midstream partners lp  whoisraisingmoneycom daily updated news about investment into startups hedge funds and private equity companies athyrium opportunities fund iii nonus a lp  pooled investment fund ferrell formdscom  sec filings of fundraisings and investments in hedge funds private equity firms startups and growing companies formdscom newest filter local athyrium opportunities fund iii nonus a lp industry pooled investment fund see others in industry address co athyrium capital management lp 5 fifth avenue floor 5 new york ny 0phone 65 filings date filingtype reported sold incremental cash type exemptions link to raw filing  new   other b c c sec link directors and executives current and past name role jeffrey a ferrell executive andrew c hyman executive jeremy d lack executive courtney paul executive elin strong executive paul a wakefield executive athyrium capital management and neuberger berman close  billion healthcare fund athyrium capital management and neuberger berman close  billion healthcare fund jul 0 05 0 et from neuberger berman from athyrium neuberger berman founded in  is a private independent employeeowned investment manager the firm manages equities fixed income private equity and hedge fund portfolios for institutions and advisors worldwide with offices in 8 countries      facebook twitter pinterest athyrium     facebook twitter pinterest neuberger berman founded in  is a private independent employeeowned investment manager the firm manages equities fixed income private equity and hedge fund portfolios for institutions and advisors worldwide with offices in 8 countries neuberger bermans team is more than  professionals tenured stable and longterm in focus the firm fosters an investment culture of fundamental research and independent thinking for more information please visit our website at wwwnbcom athyrium new york july 0 05 prnewswire  athyrium capital management lp an asset management company focused on opportunities in the global healthcare sector and neuberger berman a private independent employeeowned investment manager are pleased to announce the closing of athyrium opportunities fund ii the fund or athyrium opportunities ii which seeks to make structured capital investments in global commercialstage healthcare companies athyrium opportunities ii was oversubscribed closing at over  billion the funds global investor base is comprised of more than  institutions including public and private pensions endowments foundations and sovereign wealth funds a number of which also invested in the first athyrium opportunities fund which closed in may 0 athyrium capital now advises funds with over  billion of committed capital athyrium opportunities ii seeks to make 550 million investments in commercialstage healthcare companies in north america europe asia and australia  the fund invests across all healthcare verticals including biopharma medical devices diagnostics healthcare services and healthcare information technology  financings by the fund can be made in both public and private companies  the fund focuses on partnering with management teams who are looking for longterm capital to grow their businesses  the fund has significant flexibility in structuring investments – possible transaction structures include loans notes convertible securities preferred stock and other equity royalties royaltybacked debt or other structured instruments – allowing the implementation of creative financing solutions to meet capital needs  the fund has made six investments to date representing over  of committed capital  the funds senior investment team is comprised of jeff ferrell founder of athyrium capital laurent hermouet jeremy lack richard pines and hondo sen partners at athyrium capital and samuel porat managing director at neuberger berman  neuberger bermans alternatives business nb alternatives is a sub advisor to the fund  nb alternatives and athyrium capital formed a strategic relationship in  to raise and deploy capital in structured investments across the healthcare sector athyrium capital has a strong track record of providing large flexible and longterm capital solutions at attractive costs of capital said jeff ferrell  our deep experience and expertise in the healthcare sector allows us to quickly assess opportunities and to be valueadd partners with our portfolio companies our aim is to teamup with high quality management teams to help fund their companies growth said jeremy lack   our customtailored financings are often used for acquisitions growth acceleration and other forms of expansion we are grateful for the ongoing support of our existing investors and we welcome the addition of several new wellrespected institutions to the fund said samuel porat  about neuberger berman neuberger berman founded in  is a private independent employeeowned investment manager the firm manages equities fixed income private equity and hedge fund portfolios for institutions and advisors worldwide with offices in 8 countries neuberger bermans team is more than  professionals and the company was named by pensions  investments as a 0 and 04 best place to work in money management tenured stable and longterm in focus the firm fosters an investment culture of fundamental research and independent thinking it manages 5 billion in client assets as of june  05 for more information please visit our website at wwwnbcom about athyrium capital management athyrium capital management lp athyrium capital is a specialized asset management company formed in 8 to focus on investment opportunities in the global healthcare sector athyrium capital manages funds with committed capital in excess of  billion the athyrium capital team has substantial investment experience in the healthcare sector across a wide range of asset classes including public equity private equity fixed income royalties and other structured securities athyrium invests across all healthcare verticals including biopharma medical devices and products and healthcare focused services the team partners with management teams to implement creative financing solutions to companies capital needs for more information please visit wwwathyriumcom all information is as of june  05 unless otherwise indicated and is subject to change without notice  firm data including employee and assets under management figures reflects collective data for the various affiliated investment advisers that are subsidiaries of neuberger berman group llc  firm history dates back to the  founding of neuberger  berman the predecessor to neuberger berman llc  this material is being issued on a limited basis through various global subsidiaries and affiliates of neuberger berman group llc please visit wwwnbcomdisclosureglobalcommunications for the specific entities and jurisdictional limitations and restrictions the neuberger berman name and logo are registered service marks of neuberger berman group llc    05 neuberger berman group llc all rights reserved media contacts andrew hyman athyrium   65 ahymanathyriumcomalex samuelson neuberger berman  6 5 alexandersamuelsonnbcom logo  httpphotosprnewswirecomprnhmm0850logo logo  httpphotosprnewswirecomprnh056logo   source neuberger berman athyrium related links httpwwwathyriumcom httpwwwnbcom view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more my news release contains wide tables view fullscreen looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search